openPR Logo
Press release

Electroencephalographs Market - Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025

07-05-2017 06:19 PM CET | Health & Medicine

Press release from: Medical Devices Industry

Electroencephalographs Market - Global Industry Insights,

Electroencephalography is used to record electrical activity of the brain using electrophysiological monitoring method, which is typically a noninvasive method where electrodes are placed along the scalp. Electroencephalographs measures voltage fluctuations resulting from ionic current within the neurons of the brain over a period of time. Also called brain waves, neural oscillations are observed in electroencephalography. Electroencephalography is most often used in diagnosis of epilepsy, which is a neurological disorder. Furthermore, electroencephalographs are used to diagnose sleep disorders, encephalopathies, coma and brain death. Electroencephalography performs first line diagnosis of tumors, stroke and brain death disorders. Moreover, electroencephalographs are valuable tools for research diagnosis, especially when millisecond-range temporal resolution in required which is not possible with CT or MRI. Research in field of neuroscience, psychophysiological, neurolinguistics, cognitive psychology and cognitive science.

Furthermore, Alzheimer’s disease is also diagnosed by electroencephalograph, which is a disorder that affects the brain. Certain psychoses and sleep disorder called narcolepsy are also diagnosed by electroencephalographs. Electroencephalographs are also used to determine electrical activity of the brain overall is case of trauma, drug intoxication or extent of brain damage. Blood flow in brain during surgical process is also monitored by electroencephalographs.

Request a sample copy of this report:https://www.coherentmarketinsights.com/insight/request-sample/505

Electroencephalographs Market Taxonomy

By Product Type

Patient Monitors
Transmitters

By Application

Intensive Care
Infant

By End User

Hospitals
Research Laboratories

Rising incidence of mental illness is expected to fuel the growth of electroencephalographs market in the near future

The rise in incidence of brain disorders such as Alzheimer’s disease, epilepsy and psychiatric illness has significantly increased the market of electroencephalographs. According to the annual report of Alzheimer’s Association (AA), it was estimated that 5.4 million people in the U.S. suffer from Alzheimer’s disease in 2012 and by 2050, it is estimated that between 11 million to 16 million people in the U.S. will suffer from Alzheimer’s disease, with one new case appearing every 33 seconds. Moreover, Alzheimer’s disease International showed that 35.6 million people suffered from Alzheimer’s disease worldwide in 2010. Moreover, according to WHO, published facts list updated on Feb 2017 50 million suffer from epilepsy which fuels the market of electroencephalographs. Furthermore, according to WHO, depression was the third-leading cause of disease burden worldwide, where mental and behavioral disorder contributed 7.4% and neurological disorder 3% in 2010 which determines the increase in market of electroencephalographs.

Regional growth engines of electroencephalographs market

Mental illness is most prominently observed in the North America region. Around 1 in 5 adults in U.S. that is 43.8 million, or 18.5% suffered from some form of mental illness in 2015. This creates a highly conducive environment for growth of the electroencephalographs market in the country. Moreover, the incidence of mental illness has increased in Asia, especially in India and China. According to Journal of Indian Academy of Neurology, 70 million people were suffering from epilepsy worldwide, whereas India reported 12 million of people suffering from epilepsy which contributed one-sixth of the global burden in the year 2014. The European region also offers a huge market for electroencephalographs due to rise in awareness of neurological disorders and increase in purchasing power.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/electroencephalographs-market-505

Key players supporting the growth of electroencephalographs market

Manufactures are focusing on offering advanced features to electroencephalographs at affordable prices to gain a competitive edge in the market. Key players operating in the global electroencephalograph market include HEYER Medical AG, Medicom MTD, Draeger, Inc., Natus Medical Incorporated, Masimo, NeuroWave Systems Inc., Brain Products, elmiko medical, CamNtech Ltd, Danmeter, Neurosoft and MT MonitorTechnik GmbH & CO.KG.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Electroencephalographs Market - Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025 here

News-ID: 609218 • Views: 255

More Releases from Medical Devices Industry

Cataract Surgery Devices Market - Global Industry Insights 2017 - 2025
Increasing incidence and prevalence of ocular diseases to propel the growth of global cataract surgery devices market Increasing prevalence of the ocular disorders is the major driver for the growth of global cataract surgery devices market. This disease is prevalent worldwide and is the major cause of blindness across the globe. According to All About Vision Media, A National Supporter and Sponsor of Optometry Giving Sight, cataract is the principle cause
Particulate Respirators Market Evolving Industry Trends and key Insights by 2020
Patient suffering from SARS or their surrounding people are the target population for particulate respirators Particulate respirators are medical devices, which helps to protect one from harmful particles present in the air or dust or harmful fumes. Such harmful dust usually spread through severe acute respiratory syndrome (SARS). SARS is a respiratory syndrome commonly spread among symptomatic individuals, by person-to-person contact, or when the person sneezes or coughs, thereby infecting
Sleeping Aids Market - Global Industry Insights, Trends, Outlook, and Opportunit …
Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment
Organ Preservation Market - Global Industry Insights, 2017-2025
Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and

All 5 Releases


More Releases for Alzheimer’s

Global Alzheimer’s disease, Dementia and Ageing Awareness
Lexis brings in a new spin on conferences by presenting the latest scientific improvements in the fields of Neurology and Neuroscience. Zurich is all set for an amazing event as LEXIS proudly presents the “Global Alzheimers, Dementia and Ageing Awareness” slated on July 17-18, 2019 at Zurich, Switzerland. The theme of the conference is “Global Voice and Awareness on Alzheimers Disease and Dementia Care”. Avenue Roger VAndendriessche, 18 at 1150 BRUSSELS Avenue
Global Alzheimer’s disease (AD) Market to 2024
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions Global Alzheimer’s disease (AD) market was valued at $3.1bn in 2015 and is forecast to grow at a modest 5.3% CAGR between 2015
Europe Alzheimer’s Drug Pipeline Analysis
The incidence of Alzheimer’s disease has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been observed that close to 50% of dependency of aged people in Europe is attributed for by Alzheimer’s disease. The rapid growth in the prevalence of Alzheimer's disease over the next few decades in Europe is expected to result in immense pressure
Alzheimer’s Disease Therapeutics Market Forecast – (2016-2020)
Alzheimer’s Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents Summary of the report: Alzheimer's Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first appear in patients in their mid-sixties, with symptoms appearing in varying stages. The pathological features of AD comprise histopathological changes within the brain.
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to
Alzheimer’s Association Long Island Presents Public Input Session for National …
On August 24, Alzheimer’s Association Long Island will hold a public input session to solicit views, comments and perspectives from stakeholders in the Alzheimer’s community to assist in the development of a successful National Alzheimer’s Plan. The recommendations and comments expressed during these input sessions, taking place across the country in August, will be collected and shared this fall with officials from the U.S. Department of Health and Human Services,